The prothrombin gene 20210 mutation (Thrombophilia) is a coagulation factor that is converted by activation of the coagulation mechanism to insoluble thrombin. The 20210 mutation in the prothrombin gene can lead to very high levels of prothrombin and with a corresponding increase, the possibility of thromboembolism

It is used, when we check for any cardiovascular disease and calculation of risk factors for thrombosis. It is recommended for people with :

1. personal or family medical history of thrombosis
2. treatment with contraceptives, or hormone replacement therapy
3. high-risk pregnancy (older women, twins - triplets pregnancies, etc.)
4. unexpected miscarriages

Negative in prothrombin g20210a mutation

Simple blood collection at any time of the day, without preparing food or avoiding medication

Possibility of sending a sample

For information: 210.6983.222

Results in 4-5 working days.